Citation Impact
67 standout
Citing Papers
Frailty in Older Adults
2024 Standout
Management of Menopausal Symptoms
2023 Standout
Works of B. Clemmesen being referenced
A 2-Year Phase II Study with 1-Year of Follow-up of Risedronate (NE-58095) in Postmenopausal Osteoporosis
1997
The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study
1996
Author Peers
| Author | OSM | Oncology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| B. Clemmesen | 348 | 271 | 173 | 8 | 409 | |
| Minghui Dong | 1 | 41 | 31 | 486 | ||
| Robert M. Rabin | 2 | 41 | 1.3k | |||
| Ernő Téglás | 6 | 15 | 1.3k | |||
| G. D. Dellow | 11 | 215 | ||||
| Nessie D. Luambano | 21 | 12 | 340 |
All Works
Loading papers...